GRIFOLS | Salg Og Administrasjonskostnader



Selling And Administration Expenses Endring Dato
Alcon AG USD 802M 7M 2024-12
Almirall EUR -50222000 162.22M 2024-06
Amadeus IT EUR 610.7M 45.5M 2024-12
Amarin USD 36.9M 1.64M 2024-09
argenx SE USD 285.94M 8.24M 2024-12
AstraZeneca USD 5.55B 307M 2024-12
Bayer EUR 4.34B 610M 2024-12
Cie Automotive EUR 315.66M 28.06M 2024-12
Demant DKK 5.63B 2.77B 2024-12
Ence Energia y Celulosa EUR 29.1M 2M 2024-09
Essilor EUR 3.17B 103.5M 2024-12
Ferrovial EUR 906M 52M 2024-12
Fresenius EUR 769M 68M 2024-12
Fresenius Medical Care EUR 840M 84M 2024-12
Galapagos EUR 41.25M 11.98M 2024-12
Genmab DKK 1.25B 384M 2024-12
GlaxoSmithKline GBP 2.66B 1.14B 2024-12
GRIFOLS EUR 269.48M 49.95M 2024-12
Hikma Pharmaceutical USD 280M 4M 2024-06
Merck EUR 1.41B 72M 2024-09
Novartis USD 3.5B 368M 2024-12
Philips EUR 1.33B 99M 2024-12
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.68B 26M 2024-09
Smith & Nephew USD 1.35B 12.8M 2024-12
UCB EUR 533M 434M 2024-06
Viscofan 68.07M 61.17M 2024-09



GRIFOLS Salg Og Administrasjonskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.